This publication highlights what we do best at preclinics: bridging computational antibody design with real-world efficacy.
We support nanobody development from concept to validation:
- Custom immunization programs
- Phage display screening
- Comprehensive characterization
Ready to validate your next candidate?
Congratulations Yannick Vogt on your first-author publication — a fantastic achievement! An important step toward more reliable AI-driven VHH antibody discovery by demonstrating the value of combining complementary structure prediction confidence metrics. At preclinics, we’re proud to help bridge the gap between computational antibody discovery and experimental validation by providing immunization, phage display screening, and comprehensive wet-lab characterization of both in silico-designed and in vivo-derived VHH antibodies. — Dr. Stefan Hirschberg